Suppr超能文献

一名患有致命性结肠腺鳞癌患者的高钙血症

Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.

作者信息

Links M, Ho H, Clingan P, Diamond T

机构信息

St George Hospital, Kogarah, NSW.

出版信息

Med J Aust. 1994 Mar 7;160(5):286-7.

PMID:8107631
Abstract

OBJECTIVE

To report a rare manifestation of metastatic adenosquamous carcinoma of the colon in a patient presenting with humoral hypercalcaemia of malignancy mediated by parathyroid hormone related peptide (PTHrP).

CLINICAL FEATURES

A 58-year-old man with metastatic adenosquamous carcinoma of the colon presented with hypercalcaemia. A technetium bone scan excluded osteolytic bone secondaries. A negative parathyroid subtraction scan and a low serum immunoreactive parathyroid hormone level (1-34 [amino acid fragment]) made the diagnosis of primary hyperparathyroidism unlikely. The diagnosis of humoral hypercalcaemia of malignancy was considered on the basis of an elevated serum PTHrP level and positive tumour immunoreactivity to PTHrP antiserum.

INTERVENTION AND OUTCOME

The hypercalcaemia was effectively treated on two occasions with intravenous administration of aminohydroxy propilidene diphosphonate. Despite interventional chemotherapy, the patient died of progressive carcinomatosis.

CONCLUSION

Hypercalcaemia is an extremely rare occurrence in carcinoma of the colon. This is the first documented case of humoral hypercalcaemia of malignancy associated with adenosquamous carcinoma of the colon mediated by PTHrP.

摘要

目的

报告一例罕见的结肠转移性腺鳞癌患者,其表现为甲状旁腺激素相关肽(PTHrP)介导的恶性肿瘤体液性高钙血症。

临床特征

一名58岁男性,患有结肠转移性腺鳞癌,出现高钙血症。锝骨扫描排除了溶骨性骨转移。甲状旁腺减影扫描阴性且血清免疫反应性甲状旁腺激素水平低(1-34[氨基酸片段]),排除了原发性甲状旁腺功能亢进症的诊断。基于血清PTHrP水平升高以及肿瘤对PTHrP抗血清的免疫反应阳性,考虑诊断为恶性肿瘤体液性高钙血症。

干预措施及结果

高钙血症先后两次通过静脉注射氨基羟丙基二膦酸盐得到有效治疗。尽管进行了介入化疗,患者仍死于进行性癌病。

结论

高钙血症在结肠癌中极为罕见。这是首例有文献记载的由PTHrP介导的与结肠腺鳞癌相关的恶性肿瘤体液性高钙血症病例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验